2006 Thomas Alva Edison Patent Award for Potential New Therapy for the Prevention of Osteoporosis, Awarded to Wyeth Researchers
Christopher P. Miller, Ph.D.; Michael D. Collini; Bach D. Tran; and Arthrur A. Santilli, Ph.D., received the 2006 Thomas Alva Edison Patent Award in the category of Emerging Therapies.
These researchers were granted the patent for bazedoxifene, an investigational selective estrogen receptor modulator for the prevention of postmenopausal osteoporosis.
Find more details from the press release.
Comment Preview